AMLX NASDAQ
Amylyx Pharmaceuticals, Inc.
1W: +0.4%
1M: -20.5%
3M: -0.6%
YTD: +22.0%
1Y: +152.4%
3Y: -48.8%
$13.58
-0.35 (-2.51%)
Weekly Expected Move ±5.5%
$12
$13
$13
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+100.0% YoY
$-150M
Net Income
+31.4% YoY
$-121M
Free Cash Flow
+41.8% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-63.9%
ROA-57.0%
ROIC2183.3%
Valuation
P/E-10.0
P/B5.5
EV/EBITDA-8.2
Leverage
Debt/Equity0.02
Current Ratio14.27
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z30.10
Beneish M0.00